期刊文献+

免疫磁珠分选系统在急性髓系白血病干细胞分离中的应用 被引量:5

下载PDF
导出
摘要 目的:采用免疫磁珠分选系统(MACS)分离人白血病骨髓CD34+、CD38-干细胞群。方法:收集人白血病骨髓,Percoll密度梯度离心分离单个核细胞,CD34、38磁性标记,MACS分离纯化CD34+、CD38-干细胞群,流式细胞仪检测其纯度和分选前后CD34+、CD38-百分比,计算回收率。结果:分选后的CD34+、CD38-细胞纯度达72.6±3.2%,回收率85.8±1.2%。结论:免疫磁珠分选系统是一种有效的白血病干细胞分离提纯方法,所得细胞纯度比较高。
出处 《浙江中西医结合杂志》 2008年第10期610-612,共3页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
基金 国家自然科学基金资助(30672746)
  • 相关文献

参考文献4

二级参考文献35

  • 1Karin M, Cao Y, Greten FR, et al. NF-kappa B in cancer: from innocent bystander to major culprit. Nat Rev Cancer, 2002; 2:301-310.
  • 2Kiyoi H, Towatari M, Yokota S, et al. Internal tandem duplication of the Fit3 gene is a noval modality of elognation mutation which causes constitutive activation of the produet. Leukemia, 1998; 12:1333 - 1337.
  • 3Mizuld M, Fensld R, Halfter H, et al. Fit3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STATS pathways. Blood, 2000; 96:3907- 3914.
  • 4Levis M, Allebach J, Tse KF, et al. A Flt3-targeted tyrosine kirinse inhibitor is cytotoxic to leukemia cells in vitro and in vivo.Blood, 2002; 99:3885 - 3891.
  • 5Guzman ML, Upchurch D, Grimes B, et al. Expression of tumorsuppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells. Blood.2001; 97:2177- 2179.
  • 6Lapidot T, Sirard C, Vormoor J, et al. A cell initiating humanacute myeloid leukemia after transplantation into SCID mice. Nature, 1994; 367:645- 648.
  • 7Hasse D, Feuring-Buske M, Konemann S, et al. Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopietic stem cells by cytogenetic analysis of CD34^+ subpopulations. Blood, 1995; 86:2906-2912.
  • 8Mehrotra B, George TI, Kavanau K, et al. CytogeneticaUy aberrant cells in the stern cell compartment (CD34^+ Lin^- ) in acute myeloid leukemia. Blood, 1995; 86:1139 - 1147.
  • 9Blair A, Hogge DE, Sutherland HJ. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and invivo have the phenoltype CD34( + )CD71( - )/HLA-DR^-. Blood,1998; 92:4325- 4335.
  • 10Blair A, Hogge DE, Allies LE, et al. Lack of expression of Thy-1(CD90)on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood, 1997; 89:3104-3112.

共引文献2

同被引文献54

  • 1舒赛男,魏来,方峰,王宇.免疫磁珠分选系统在分离大鼠骨髓干细胞群中的应用[J].标记免疫分析与临床,2006,13(1):35-37. 被引量:8
  • 2王光平,曹星玉,信红亚,李群,齐振华,陈方平.用Midi MACS方法从白血病患者分选CD34^+/CD123^+细胞[J].中国实验血液学杂志,2006,14(5):969-971. 被引量:8
  • 3冀冰心,徐娟,苏力,刘聪艳,董会卿.自体外周血纯化CD34^+细胞移植治疗进展型多发性硬化[J].中国神经免疫学和神经病学杂志,2007,14(2):69-72. 被引量:3
  • 4Lapidot T,Sirard C,Vormor J,et al.A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.Nature,1994,367:645-648.
  • 5Blair A,Hogge DE,Sutherland HJ.Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(-)/CD71(-)/HLA-DR.Blood,1998,92:4325-4335.
  • 6Bonnet D,Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.Nat Med,1997,3:730-737.
  • 7Blair A,Hogge DE,Ailles LE,et al.Lack of expressionof Thy-1 (CD90)on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo.Blood,1997,89:3104-3112.
  • 8Blair A,Sutherland HJ.Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD,7).Exp Hematol,2000,28:660-671.
  • 9Jordan CT,Upchurch D,Szilvassy SJ,et al.The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.Leukemia,2000,14:1777-1784.
  • 10Hosen N,Park CY,Tatsumi N,et al.CD96 is a leukemic stem cellspecific marker in human acute myeloid leukemia.Proc Natl Ac ad Sci USA,2007,104:11008-11013.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部